[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

MXPA04002401A - Nuevos medicamentos para inhalacion. - Google Patents

Nuevos medicamentos para inhalacion.

Info

Publication number
MXPA04002401A
MXPA04002401A MXPA04002401A MXPA04002401A MXPA04002401A MX PA04002401 A MXPA04002401 A MX PA04002401A MX PA04002401 A MXPA04002401 A MX PA04002401A MX PA04002401 A MXPA04002401 A MX PA04002401A MX PA04002401 A MXPA04002401 A MX PA04002401A
Authority
MX
Mexico
Prior art keywords
inhalation
novel medicaments
relates
salts
novel
Prior art date
Application number
MXPA04002401A
Other languages
English (en)
Inventor
Soyka Rainer
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2001145438 external-priority patent/DE10145438A1/de
Priority claimed from DE2002109243 external-priority patent/DE10209243A1/de
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of MXPA04002401A publication Critical patent/MXPA04002401A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

La presente invencion se refiere a nuevos medicamentos para la inhalacion sobre la base de sales de tiotropio y sales dificilmente solubles de salmeterol, a procedimientos para su preparacion, asi como a su utilizacion en la terapia de enfermedades de las vias respiratorias.
MXPA04002401A 2001-09-14 2002-09-06 Nuevos medicamentos para inhalacion. MXPA04002401A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE2001145438 DE10145438A1 (de) 2001-09-14 2001-09-14 Neue Arzneimittel zur Inhalation
DE2002109243 DE10209243A1 (de) 2002-03-04 2002-03-04 Neue Arzneimittelkombination zur Inhalation
PCT/EP2002/009974 WO2003024452A1 (de) 2001-09-14 2002-09-06 Neue arzneimittel zur inhalation

Publications (1)

Publication Number Publication Date
MXPA04002401A true MXPA04002401A (es) 2004-05-31

Family

ID=26010149

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA04002401A MXPA04002401A (es) 2001-09-14 2002-09-06 Nuevos medicamentos para inhalacion.

Country Status (8)

Country Link
EP (1) EP1429768B1 (es)
JP (1) JP2005504076A (es)
AR (1) AR036518A1 (es)
CA (1) CA2459493C (es)
MX (1) MXPA04002401A (es)
PE (1) PE20030646A1 (es)
UY (1) UY27445A1 (es)
WO (1) WO2003024452A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2165768B1 (es) 1999-07-14 2003-04-01 Almirall Prodesfarma Sa Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
DE10351663A1 (de) * 2002-12-20 2004-07-01 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pulverförmige Arzneimittel enthaltend ein Tiotropiumsalz und Salmeterolxinafoat
PL1651270T3 (pl) * 2003-07-29 2007-06-29 Boehringer Ingelheim Int Leki do inhalacji zawierające betamimetyki i środki przeciwcholinergiczne
EP1959942A1 (en) * 2005-08-06 2008-08-27 Boehringer Ingelheim International GmbH Method for the treatment of dyspnea comprising combined administration of tiotropium salts and salts of salmeterol
ES2495965T3 (es) * 2006-08-16 2014-09-17 Action Medicines, S.L. Uso de derivados 2,5-dihidroxibencénicos para el tratamiento de enfermedades oculares
EP2100598A1 (en) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
EP2100599A1 (en) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
EP2510928A1 (en) 2011-04-15 2012-10-17 Almirall, S.A. Aclidinium for use in improving the quality of sleep in respiratory patients

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1172663B (de) * 1961-04-28 1964-06-25 Maggioni & C Spa Verfahren zur Herstellung von Wismut-tri-(p-phenylcinnamat)
GB8310477D0 (en) * 1983-04-18 1983-05-25 Glaxo Group Ltd Chemical compounds
DE19726871C1 (de) * 1997-06-24 1999-03-04 Werner Kreutz Synergistisch wirkende Zusammensetzungen zur selektiven Bekämpfung von Tumorgewebe
DE19921693A1 (de) * 1999-05-12 2000-11-16 Boehringer Ingelheim Pharma Neuartige Arzneimittelkompositionen auf der Basis von anticholinergisch wirksamen Verbindungen und ß-Mimetika
WO2000061108A1 (en) * 1999-04-14 2000-10-19 Glaxo Group Limited Pharmaceutical aerosol formulation
DE10056104A1 (de) * 2000-11-13 2002-05-23 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Tiotropiumsalzen und Salzen des Salmeterols

Also Published As

Publication number Publication date
EP1429768A1 (de) 2004-06-23
CA2459493C (en) 2011-08-02
CA2459493A1 (en) 2003-03-27
WO2003024452A1 (de) 2003-03-27
PE20030646A1 (es) 2003-07-23
UY27445A1 (es) 2003-04-30
EP1429768B1 (de) 2016-11-16
JP2005504076A (ja) 2005-02-10
AR036518A1 (es) 2004-09-15

Similar Documents

Publication Publication Date Title
YU35503A (sh) Nove kompozicije lekova bazirane na solima tiotropijuma i solima salmeterola
IL164291A0 (en) Medicaments containing betamimetic drugs and a novel anticholinesterase drug
RS20050484A (en) Powdered medicament for inhalation comprising a tiotropium salt and salmeterol xinafoate
YU71901A (sh) NOVE VRSTE LEKOVITIH KOMPOZICIJA NA BAZI JEDINJENJA KOJA DELUJU ANTIHOLINERGIJSKI I beta-MIMETIKA
WO2004037807A3 (en) Medicinal arylethanolamine compounds
YU36302A (sh) Novi tiotropiumski preparati - koji sadrže prah za inhaliranje
UA85708C2 (ru) Лекарственные комбинации, содержащие бензоксазины, для лечения заболеваний дыхательных путей
WO2008022189A3 (en) Administration of high potency platinum compound formulations by inhalation
AU2002316771A1 (en) Guanylate-cyclase c ligand, administered via the airways, for the treatment of respiratory airway problems
WO2003087049A3 (de) Arzneimittelkombinationen enthaltend heterocyclische verbindungen und ein neues anticholinergikum
RS20060293A (en) Novel tiotropium salts, methods for the production thereof, and pharmaceutical formulations containing the same
SG137859A1 (en) Method for producing tiotropium salts, tiotropium salts and pharmaceutical formulations, containing the same
MXPA06013221A (es) Formulaciones en polvo para la inhalacion, las cuales contienen beta-agonistas enantiomericamente puros.
MXPA04002401A (es) Nuevos medicamentos para inhalacion.
RS89904A (en) Medicaments containing steroids and a novel anticholinesterase drug
RS20050400A (en) Pulverulent formulation for inhalation containing tiotropium
ATE452639T1 (de) Arzneimittelkompositionen aus tiotropiumsalzen und epinastin zur therapie von atemswegserkrankungen
WO2004105759A3 (de) Neue langwirksame arzneimittelkombinationen ein anticholinergikum und einen beta-2-adrenorezeptorantantonisten enthaltend zur behandlung von atemwegserkrankungen
MXPA03008406A (es) Nuevas composiciones de medicamentos sobre la base de agentes anticolinergicos y agentes antagonistas de endotelina.
DE50309096D1 (de) Tiotropiumhaltige arzneimittelkombination fuer die inhalation
MY141724A (en) Medicaments containing betamimetic drugs and a novel anticholinesterase drug
WO2005007134A8 (de) Pulverformulierungen für die inhalation enthaltend ein neues anticholinergikum
MXPA03005585A (es) Nuevas composiciones de medicamentos a base de anticolinergicos y agonistas de dopamina.

Legal Events

Date Code Title Description
FG Grant or registration